A groundbreaking study reveals that a combination of rapamycin and trametinib extends the lifespan of mice by up to 30%, while also improving their health in old age. The drug cocktail reduced inflammation, delayed tumor growth, and enhanced physical function. This discovery offers hope for developing anti-ageing treatments for humans, potentially slowing or reversing ageing-related decline.
